News

Pharmabiz12h
Ensem Therapeutics doses first patient in phase 1/2 study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader
Ensem Therapeutics doses first patient in phase 1/2 study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Thursday, July 3 ...
Pharmabiz13h
CBI searches premises of PCI president Montu Kumar Patel, say reports
CBI searches premises of PCI president Montu Kumar Patel, say reports: Our Bureau, New Delhi Thursday, July 3, 2025, 17:25 Hrs [IST] The Central Bureau of Investigation (CBI) has ...
Pharmabiz13h
KSPC launches maiden virtual simulation-based pharma manufacturing training programme
KSPC launches maiden virtual simulation-based pharma manufacturing training programme: Our Bureau, Bengaluru Thursday, July 3, 2025, 17:15 Hrs [IST] Karnataka State Pharmacy Counc ...
Pharmabiz13h
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use: Eindhoven, the Netherlands Thursday, July ...
Pharmabiz13h
Industry leaders support Covid-19 vaccines following Karnataka CM's remarks
Industry leaders support Covid-19 vaccines following Karnataka CM's remarks: Our Bureau, New Delhi Thursday, July 3, 2025, 16:30 Hrs [IST] After the Central government, the indust ...
Pharmabiz14h
Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent
Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent: Uppsala, Sweden Thursday, July 3, 2025, 16:00 Hrs [IST] Uppsala-headquartered Senzime, a leadi ...
Pharmabiz15h
Hemispherian’s GLIX1 to treat malignant glioma receives US FDA orphan drug designation
Hemispherian’s GLIX1 to treat malignant glioma receives US FDA orphan drug designation: Oslo, Norway Thursday, July 3, 2025, 15:00 Hrs [IST] Hemispherian AS, an Oslo-based pharm ...
Pharmabiz16h
Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide
Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide: Chelmsford, Massachusetts Thursday, July 3, 202 ...
Pharmabiz17h
Sobi to amend existing agreement with Apellis for ex-US royalties of Aspaveli
Sobi to amend existing agreement with Apellis for ex-US royalties of Aspaveli: Stockholm, Sweden Thursday, July 3, 2025, 13:00 Hrs [IST] Sobi, a global biopharma company, announce ...
Pharmabiz18h
IDMA Telangana meets DG of Telangana DCA to address key issues facing pharma industry in the state
IDMA Telangana meets DG of Telangana DCA to address key issues facing pharma industry in the state: Our Bureau, Mumbai Thursday, July 3, 2025, 12:10 Hrs [IST] The Telangana State ...
Pharmabiz18h
Novocure to present final secondary endpoint data from phase 3 PANOVA-3 trial at ESMO Congress 2025
Baar, Switzerland Thursday, July 3, 2025, 12:00 Hrs [IST] ...
Pharmabiz19h
Tamil Nadu state pharmacy council elects new members
The 9th Tamil Nadu state pharmacy council election concluded on Wednesday morning, July 2nd, with the returning officer announcing the results in the afternoon. Six candidates who secured the highest ...